Tag: drug prices

December 8, 2021

A drug company previously owned by Martin Shkreli, known as “Pharma Bro,” and its parent company have agreed to pay up to $40 million to settle a complaint over allegations they “fleeced patients” by hiking up the price of a […]

January 7, 2020

Bank of America expects European stocks broadly to rise this year, but its key underweight call is the pharmaceutical sector, and the recommendation has nothing to do with talk of reining in U.S. drug prices. Bank of America’s call on […]

July 11, 2019

The Trump administration has abandoned a centerpiece of its efforts to address high drug prices, backing away from requiring some discounts to be passed directly to consumers under Medicare that could have lowered their out-of-pocket costs. President Trump had announced […]

March 8, 2019

With drug prices rising sitting at 10% of skyrocketing health care costs and pharmaceutical companies socking away big profits, you might assume that the U.S. has the highest prescription drug spending in the world. And you’d be right. Per capita […]

February 15, 2019

A new study shows something many healthcare patients know all too well: hospitals are charging significant premiums on some of the most-used prescription drugs. In a new study of 34 hospital systems, Wall Street firm AllianceBernstein found that the average […]

May 11, 2018

Before you ever walk up to the counter at your local pharmacy, a lot has already happened to get your prescription drug ready for pickup. For a single prescription drug, there are often five companies involved, from development all the […]

April 26, 2018

The outlook was grim for Novo Nordisk at the end of 2016. As pressure mounted over its rising insulin prices, investors drove the stock down by a third, fearing that lawmakers would cap price tags and hurt profits. So last […]

February 22, 2017

A new patient advocacy group launches Wednesday that distinguishes itself by focusing only on drug prices and eschewing money from the pharmaceutical industry at a time when drug makers are pouring millions into a campaign fighting efforts to regulate them. The formation of […]